Navigation Links
Study Ties Gene to Dangerous Heart Valve Deposits
Date:2/6/2013

WEDNESDAY, Feb. 6 (HealthDay News) -- Researchers have identified a gene variant that doubles the risk of having calcium deposits on the heart's aortic valve.

Severe aortic valve calcification can cause narrowing or blockage of the aortic valve, a condition called aortic stenosis, which can prevent the proper amount of blood from reaching the brain and the rest of the body.

Researchers analyzed genetic data from thousands of people and found that a genetic variant of the LPA gene was strongly associated with having aortic valve calcification on a CT scan and increased the risk of developing aortic stenosis by more than 50 percent.

The LPA gene codes for a type of cholesterol particle called lipoprotein (a), which circulates in the blood and is associated with increased risk of heart attack. Previous studies have linked lipoprotein (a) with aortic valve disease, but this study is believed to be the first to provide evidence that it may actually play a role in the disease.

The findings, published in the Feb. 7 issue of the New England Journal of Medicine, could help explain why aortic valve calcification runs in families. It might also lead to the development of new drugs to slow the progression of the disease.

"This is an important step forward in understanding the biology of the development of aortic stenosis and how this common genetic variant, which is found in 7 percent of the general population, contributes to that risk," study senior author Dr. Wendy Post, a cardiologist and associate professor of medicine and epidemiology at the Johns Hopkins University School of Medicine in Baltimore, said in a university news release.

Non-genetic risk factors for aortic valve calcification include older age, high blood pressure, obesity, high cholesterol levels and smoking. Men are more likely than women to develop aortic valve calcification.

More information

The U.S. National Heart, Lung, and Blood Institute has more about heart valve disease.

-- Robert Preidt

SOURCE: Johns Hopkins Medicine, news release, Feb. 6, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Electrical Brain Stimulation Plus Drug Fights Depression: Study
2. Mayo Clinic-led study identifies biomarkers for early risk assessment of acute kidney injury
3. Study to test whether hearing aids can help prevent falls
4. Study identifies skiers who can be successfully treated without surgery after an ACL tear
5. Study of brain cooling and clot-busting drug therapy for stroke receives FDA OK to expand
6. Shift to Hospice Care Often Comes Too Late, Study Finds
7. Steroid Shots for Tennis Elbow Miss the Mark: Study
8. Diabetes Drug May Offer Modest Weight Loss for Very Obese Teens: Study
9. Mammogram every 2 years has same benefit as yearly mammogram for older women, UCSF study finds
10. Sunshine Linked to Lower Rheumatoid Arthritis Risk: Study
11. Patient Involvement Lowers Health Costs, Study Says
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Ties Gene to Dangerous Heart Valve Deposits
(Date:2/10/2016)... IN (PRWEB) , ... February 10, 2016 , ... ... benefits advisory organization, welcomes S.S. Nesbitt as the latest addition to its growing ... has seven other locations throughout the Southeast, from Orlando to Huntsville and in ...
(Date:2/10/2016)... ... ... Armune BioScience signed a definitive agreement with ARCpoint Labs ... the country. Launched in April of 2015, Apifiny is the only cancer specific, non-PSA ... volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized Apifiny ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact ... , Pioneering book "Better with Age: The Ultimate Guide to Brain Training" by award-winning ... improve memory. The book’s publication date is March 16, 2016. A free review ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined the award-winning ... to physicians. The integration will enable Allscripts users to post open appointments to ... mobile app. , The partnership gives Everseat substantial added power to help Allscripts ...
(Date:2/10/2016)... ... ... Workrite Ergonomics this week announced the launch of the Conform Monitor Arm Series, ... was to develop a product from the ground up that would provide the most ... Hulsey, Product Manager for Workrite Ergonomics. “The Conform series features a wide variety ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... BASEL, Switzerland and SAN DIEGO ... Houston , Inc., a global leader in viral gene ... gene therapy treatments for congestive heart failure and other ... to develop a scalable manufacturing process and produce cGMP-grade ... clinical trials. --> ...
(Date:2/10/2016)... Immune Pharmaceuticals Inc. (NASDAQ: IMNP ), ... has filed a patent application directed to the treatment ... --> --> The new invention ... (histamine dihydrochloride) in combination with immune checkpoint inhibitors. The ... of Ceplene and IL-2 therapy in patients with Acute ...
(Date:2/10/2016)... ANGELES , Feb. 10, 2016  Oxis International ... cancer drug, OXS-1550, was described as a "clinical trial ... the drug went into complete cancer remission. ... University of Minnesota Masonic Cancer Center. --> ... University of Minnesota Masonic Cancer Center. --> ...
Breaking Medicine Technology: